Florida International University

FIU Digital Commons
Environmental Health Sciences

Robert Stempel College of Public Health & Social
Work

7-13-2017

Contribution of Inhibitor of DNA Binding/
Differentiation-3 and Endocrine Disrupting
Chemicals to Pathophysiological Aspects of
Chronic Disease
Vincent Avecilla
Department of Environmental Health Sciences, Florida International University

Mayur Doke
Department of Environmental Health Sciences, Florida International University

Quentin Felty
Department of Environmental Health Sciences, Florida International University, feltyq@fiu.edu

Follow this and additional works at: https://digitalcommons.fiu.edu/eoh_fac
Part of the Medicine and Health Sciences Commons
Recommended Citation
Avecilla, Vincent; Doke, Mayur; and Felty, Quentin, "Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine
Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease" (2017). Environmental Health Sciences. 24.
https://digitalcommons.fiu.edu/eoh_fac/24

This work is brought to you for free and open access by the Robert Stempel College of Public Health & Social Work at FIU Digital Commons. It has
been accepted for inclusion in Environmental Health Sciences by an authorized administrator of FIU Digital Commons. For more information, please
contact dcc@fiu.edu.

Hindawi
BioMed Research International
Volume 2017, Article ID 6307109, 22 pages
https://doi.org/10.1155/2017/6307109

Review Article
Contribution of Inhibitor of DNA Binding/Differentiation-3
and Endocrine Disrupting Chemicals to Pathophysiological
Aspects of Chronic Disease
Vincent Avecilla, Mayur Doke, and Quentin Felty
Department of Environmental & Occupational Health, Florida International University, Miami, FL, USA
Correspondence should be addressed to Quentin Felty; feltyq@fiu.edu
Received 22 November 2016; Revised 15 February 2017; Accepted 29 May 2017; Published 13 July 2017
Academic Editor: Koichiro Wada
Copyright © 2017 Vincent Avecilla et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The overwhelming increase in the global incidence of obesity and its associated complications such as insulin resistance,
atherosclerosis, pulmonary disease, and degenerative disorders including dementia constitutes a serious public health problem.
The Inhibitor of DNA Binding/Differentiation-3 (ID3), a member of the ID family of transcriptional regulators, has been shown to
play a role in adipogenesis and therefore ID3 may influence obesity and metabolic health in response to environmental factors. This
review will highlight the current understanding of how ID3 may contribute to complex chronic diseases via metabolic perturbations.
Based on the increasing number of reports that suggest chronic exposure to and accumulation of endocrine disrupting chemicals
(EDCs) within the human body are associated with metabolic disorders, we will also consider the impact of these chemicals
on ID3. Improved understanding of the ID3 pathways by which exposure to EDCs can potentiate complex chronic diseases in
populations with metabolic disorders (obesity, metabolic syndrome, and glucose intolerance) will likely provide useful knowledge
in the prevention and control of complex chronic diseases associated with exposure to environmental pollutants.

1. Introduction
Inhibitor of DNA Binding/Differentiation-3 is a member of
the ID family of helix-loop-helix proteins encoded by an
immediate-early gene responsive to mitogenic signals and
oxidative stress. ID3 functions as a transcriptional regulator
known to prevent stem cell differentiation and promote cell
cycle progression. An increasing body of evidence suggests
that ID3 may be involved in metabolic perturbations characterized by insulin resistance, hyperglycemia, abdominal
obesity, dyslipidemia, and hypertension. Interactions across
multiple organ systems that contribute to metabolic perturbations present a challenge to ongoing research attempting
to elucidate biological mechanisms of chronic disease associated with metabolic health. For instance, insulin resistance
and systemic low-grade inflammation result from complex
interactions between the vasculature, metabolic tissue, and
immune cells. With regard to these interactions, it is noteworthy that ID3 plays a significant role in vasculogenesis, energy

metabolism, and development of the immune system. In
the vasculature, ID3 is essential to embryonic vasculogenesis
and endothelial cell activation [1–3]. Given that metabolic
perturbations are observed in endothelial cells from diseased
vasculature [4], ID3 may mediate endothelial dysfunction
often found in individuals with metabolic syndrome. In
addition to the vasculature, ID3 function spans to metabolic
tissue and immune cells. In vivo studies have demonstrated
that ID3 mediates high fat diet-induced obesity and promotes
obesity-induced inflammatory macrophage accumulation [5,
6]. Thus, we intend to discuss the current understanding of how ID3 may influence chronic diseases associated
with metabolic perturbations. Since adipose tissue is an
endocrine organ as well as a metabolic organ, exposure to
endocrine disrupting chemicals (EDCs) may also contribute
to metabolic perturbations associated with chronic disease.
EDCs are mostly synthetic chemicals ubiquitously found
in our environment that act by altering hormone action.
Estrogenic EDCs such as diethylstilbestrol (DES), bisphenol

2
A (BPA), estrogenic polychlorinated biphenyls (PCBs), and
phthalates have been implicated to interfere with metabolic
health during critical periods of development and into adulthood. Epidemiological studies have reported associations
between exposure to EDCs and metabolic syndrome [7–9].
Based on our recent findings that showed ID3 dependent
endothelial cell activation by exposure to estrogenic PCB
congener 153 [10, 11], we will also discuss how low-dose EDC
exposure from the environment may potentiate complex
chronic disease in populations with metabolic disorders
(obesity, metabolic syndrome, and glucose intolerance) via
ID3. A better understanding of interactions between ID3
and EDC is critical in deepening our understanding of how
environmental factors modify chronic disease risk and health
outcomes. Further study in these areas may reveal novel
or more effective therapeutic modalities as well as provide
prevention and control strategies of complex chronic diseases
associated with exposure to EDCs.

2. Inhibitor of DNA
Binding/Differentiation-3 (ID3)
2.1. Structure and Function. The ID (Inhibitor of DNA Binding/Differentiation) family of small proteins consists of four
genes (ID1-ID4). The four members of the ID family share
extensive amino acid sequence homology (69–78%) within
their helix-loop-helix (HLH) domain [12, 13], but the remaining parts of the proteins are nonrelated. Experimental studies
in genetically engineered mice have revealed the importance
of ID3 in embryonic development and cell differentiation.
ID3 gene knockout mice are viable; however, they have
demonstrated defects in immune cell differentiation [14, 15].
In contrast, double ID1/ID3 knockout mice showed abnormal
vascularization of the brain [16], neuronal differentiation, and
cardiac defects [17] that were embryonically lethal. Resistance
to tumor angiogenesis was reported in mice deficient in 1–3
alleles of ID1/ID3 gene knockout combination [12]. ID3 is
highly expressed in embryonic tissue but declines as cells
differentiate [12]. In adult tissues, the expression of ID3 is
context specific and tends to be highest in proliferating and
undifferentiated cells. ID3 expression has been reported to be
induced by diverse stimuli in many cell types [18].
The ID3 gene was initially identified as a serum-inducible
immediate-early gene in mouse fibroblasts that peaks transcriptionally at 1 h [14, 19]. Subsequently, ID3 expression
has been reported to be biphasic with maximal stimulation
at 1 h following a second burst at 24 h as in the case of
tissue regeneration after injury. We and others have shown
that ID3 expression is redox sensitive [1, 20]. Specifically,
we have shown that vascular endothelial cells exposed to
either 17𝛽-estradiol (E2) or the estrogenic PCB congener 153
(PCB153) resulted in increased ID3 expression, protein phosphorylation, and endothelial neovascularization. Treatment
with reactive oxygen species scavengers inhibited estrogenic
chemical induced neovascularization [10, 21]. Proteasomes
reportedly degrade ID3 by an ubiquitin dependent mechanism. The protein half-life of ID3 has been demonstrated to
be approximately 20 min in HEK293 cells [13]. In mammals,
ID protein-protein interactions occur via the HLH motif
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in which ID proteins dimerize and block the DNA binding
activity of basic HLH transcription factors, such as a group of
E proteins (E12/E47, E2-2, and HEB) encoded by the TCF3,
TCF4, and TCF12 gene, respectively. Among these E proteins,
ID3 has been most often reported to interact with E12/E47
[22]. The E proteins are basic HLH transcription factors that
bind to the E-box consensus sequence (CANNTG) in the
promoter of target genes. ID3 plays an important role in cell
proliferation via its interactions with E proteins. For example,
E proteins have been shown to bind the E-box sequence in
the promoter of the cyclin dependent kinase inhibitor p21Cip1
and activate its transcription [23]. The level of p21Cip1 is
elevated in quiescent cells where it acts as a suppressor of
cell proliferation [24]. In the context of the cell cycle, ID3
promotes cell cycle progression by the inhibition of p21Cip1
expression [25]. Specifically, ID3 protein-protein interactions
with E proteins can disrupt their ability to bind gene promoters and thereby block transcriptional activation by these
factors. ID3 has been shown to inhibit E proteins from
activating the p21Cip1 promoter in proliferating vascular cells
[26]. Thus, ID3 has been frequently described as a dominant
negative inhibitor of E proteins. Although ID proteins have
been shown to function as dominant negative transcriptional
regulators of E proteins, there may be circumstances by which
ID3 acts as a positive transcriptional regulator. ID3 has been
shown to regulate the binding of transcription factor 3 (TCF3)
to the E-box motif in target gene promoters [27]. TCF3
has been reported to repress the expression of pluripotency
genes OCT4, SOX2, and NANOG that contribute to cell
differentiation [14]. Our research has shown that ectopic
overexpression of ID3 increased OCT4 and SOX2 expression
in endothelial cells and resulted in a population of cells
that were positive for the molecular stemness signature
CD133+ VEGFR3+ CD34+ [28]. These endothelial stem cells
were morphologically differentiated into smooth muscle cells
and neuron cells. Based on these lines of evidence, ID3
maintains cells in an undifferentiated or noncommitted state
by preventing the repression of pluripotency factors by TCF3.
Hence, it is also plausible for ID3 to function as a positive
regulator of gene transcription. In lieu of a recent report
that showed ID3 to modulate genes essential for maintaining
genome integrity during cell division [29], a dual regulatory
role of ID3 in both positive and negative gene transcription
expands its influence as shown in Figure 1. ID3 proteinprotein interactions are not exclusive to E proteins as ID
proteins have also been reported to bind to proteins that do
not contain the HLH motif such as caveolin-1 [30].
2.2. ID3 and Metabolic Syndrome (MetS). There has been
increasing evidence that ID3 plays a role in adipogenesis.
ID3 through adiponectin is considered to improve 𝛽-cell
function, circulating lipids, and insulin sensitivity levels [31,
32]. ID3 inhibits transcriptional activity of E47 in undifferentiated preadipocytes [6]. ID3 negatively inhibits the FAS
(fatty acid synthase) promoter via SREP-1c in adipose tissue.
ID3 furthermore plays a role in blood glucose, which if
dysregulated can lead to insulin resistance. In human islet
cells ID1 and ID3 mRNA levels are increased with addition of
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Figure 1: ID3 transcriptional regulation. Scheme illustrating how ID3 can repress expression of p21 gene (a) or activate gene expression of
embryonic transcription factors (b).

glucose [33]. The induction of ID1 and ID3 expression, insulin
secretion, and gene transcription suggests that IDs may play
a role in promoting 𝛽-cell function [33, 34].
2.3. ID3 and Endocrine Disrupting Chemicals Influence
Metabolic Perturbation. Metabolic syndrome (MetS) and its
associated complications such as insulin resistance, abdominal obesity, dyslipidemia, and hypertension contribute to
chronic diseases including cardiovascular disease (CVD),
type 2 diabetes, cancer, and chronic kidney disease (CKD).
Some studies have shown the prevalence of MetS in the
United States at approximately 34% of the adult population
[35]. MetS is an illness of energy consumption and storage
which is a diagnosis of the cooccurrence of a minimum of
three of the following medical conditions: abdominal obesity,
high triglyceride levels, low HDL cholesterol levels, high
fasting blood sugar, and high blood pressure. The molecular
mechanisms of MetS are not fully understood. Most patients
are older, sedentary, and obese and have a certain amount of
insulin resistance. Important factors that are associated with
MetS can include aging, diet, sedentary behavior, genetics,
excessive alcohol use, or low physical activity [16, 36–38].
MetS appears to have three conceivable etiological groupings:
obesity and disorders of adipose tissue; insulin resistance; and
a collection of independent factors (e.g., molecules of hepatic,
vascular, and immunologic origin).
Inflammatory factors produced during obesity are a
major pathway for developing metabolic perturbation which
can lead to MetS. Experimental studies have demonstrated
ID3 to be a key regulator of monocyte chemoattractant
protein-1 (MCP-1) [39]. MCP-1 is a well-known chemokine
impacted by MetS [40]. ID3 has also been reported to
regulate the production of interleukins IL-5, IL-6, IL-8,
and IL-10 [41–43]. The induction of these chemokines has
been observed in population studies of obesity and/or MetS.
ID3 is also an oxidative stress regulated gene which may
provide a positive feedback pathway in response to metabolic
perturbations [1, 20]. Taken together, these lines of evidence
provide the basis for how ID3 can participate in metabolic

perturbations via controlling the expression of inflammatory
factors involved in obesity and/or MetS. A growing number
of reports implicate endocrine disrupting chemicals (EDCs)
as an environmental factor that contributes to the occurrence
of MetS. We performed a comprehensive search in the
Comparative Toxicogenomic Database (CTD) to identify
known ID3 and EDC interactions with results shown in
Table 1 [44].
Adipose tissue is highly connected to steroid hormones
(estrogens, androgens, and glucocorticoids) and maintains a
close relationship with the immune system via adipokines.
Endocrine disruption can interfere with the creation, discharge, breakdown, elimination, and imitation of natural
hormones [45]. EDCs can be cataloged into multiple groupings such as dioxins, organotins, plastics, and pesticides. The
increased presence of EDCs in the environment may help
explain the incidence of metabolic disorders and associated
complications. EDCs are found in everyday products (including food, plastic bottles, metal cans, toys, cosmetics, and
pesticides) and used in the manufacture of food. Exposure
to EDCs may regulate inflammatory factors via ID3. TCDD
and PCB congeners have been shown to upregulate MCP1 expression [46]. Bisphenol A exposure has been reported
to increase IL-6 [47]. Population studies furthermore have
reported an association between bisphenol A plasma levels
and proinflammatory cytokines including IL-6 [48].
Besides inflammation, ID3 may contribute to other risk
factors of MetS such as angiogenesis, adipose tissue, blood
glucose levels, and insulin resistance. PCBs have been associated with MetS in epidemiological studies [49]. In the
mouse model, PCB153 has been shown to produce significant
metabolic changes when administered with a high fat diet
that were consistent with worsened obesity and nonalcoholic
fatty liver disease pathology [50]. ID3 may contribute to MetS
via visceral fat expansion that was demonstrated in mice
fed a high fat diet [5]. ID3 deficiency resulted in greater
energy expenditure and higher metabolic rate in mice at
rest. With respect to metabolic disorders involving high
glucose levels, ID3 may be impacted because it was shown
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Table 1: ID3 and endocrine disrupting chemicals (EDCs) interactions. Table created from CTD (Comparative Toxicogenomic Database).
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Interaction
Methyl methanesulfonate
results in decreased expression
of ID3 mRNA
Methylnitrosourea results in
decreased expression of ID3
mRNA
Monobutyl phthalate results in
increased expression of ID3
mRNA
Mustard gas results in
increased expression of ID3
mRNA
n-Butoxyethanol results in
decreased expression of ID3
mRNA
Nickel sulfate results in
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Interaction
7,8-Dihydro-7,8dihydroxybenzo(a)pyrene
9,10-oxide results in decreased
expression of ID3 mRNA

Bis(4-hydroxyphenyl)sulfone
results in increased expression
of ID3 mRNA
Bismuth tripotassium dicitrate
results in increased expression
of ID3 mRNA
tert-Butylhydroperoxide
results in increased expression
of ID3 mRNA
C646 compound results in
decreased expression of ID3
mRNA
Cadmium sulfate affects the
reaction [MTF1 affects the
expression of ID3 mRNA]
Cobaltous chloride results in
decreased expression of ID3
mRNA
Copper sulfate results in
increased expression of ID3
mRNA

Cuprizone affects the
expression of ID3 mRNA
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to be regulated by glucose in pancreatic islet 𝛽-cells [33] and
under chronic hyperglycemic conditions. ID family proteins
were stabilized which in turn activated metabolic genes
[51]. Since a causal link of diabetes and vascular disease is
chronic hyperglycemia, ID3 may also contribute to metabolic
perturbations from high blood glucose levels. More importantly, however, mitochondrial reactive oxygen species (ROS)
produced by vascular endothelial cells under hyperglycemic
conditions may share a pathway similar to environmental
toxicant induced oxidative stress which converges on ID3.
PCBs have been reported to have estrogenic activity [52–
55]. PCB153 is an agonist for the pregnane X receptor (PXR)
and the constitutive androstane receptor (CAR) which exert
their effects on energy metabolism through gene regulation
[56]. Hence, dysregulation of these receptors by EDCs may
contribute to PCB-induced metabolic perturbations. Several
epidemiological studies have reported the association of PCB
exposure with the increased risk of cardiovascular disease
[57–61]. Since cardiovascular disease is a chronic disease
affected by metabolic perturbations, we investigated the
effects of PCB153 exposure on ID3 in vascular cells. Based
on known PCB blood levels from occupational exposure, we
showed a significant increase in PCB153-induced vascularization at doses of 10–100 ng/mL which was ID3 dependent
[11]. We have shown that PCB-induced ROS mediated a
highly branched neovascular phenotype depending on ID3
and Pyk2 [10]. Because the level of ID3 protein is determined
by the rates of protein synthesis and protein degradation,
we tested if PCB153 treatment affected ID3 protein synthesis. We showed that estrogenic chemical induced ID3 did
not depend on protein synthesis; instead PCB153 treatment
increased ID3 protein stability in endothelial cells. The role
of phosphorylation in the regulation of ID3 protein stability is
not known. A search with the PhosphoMotif finder program
revealed that ID3 had 38 serine kinase/phosphatase motifs
and 8 tyrosine kinase/phosphatase motifs [62]. We reported
that both E2 and PCB153 induced ID3 phosphorylation. E2
treatment stabilized ID3 protein during the 1–6 h treatment
time points and increased phosphorylated ID3 levels [10,
21]. It was noteworthy that we showed data of ID3 tyrosine
phosphorylation by PCB153 treatment which was confirmed
by MALDI-TOF MS/MS spectra data. Our findings revealed
phosphorylated amino acids Tyr-11 and Tyr-48 in peptides
from ID3. Interestingly, Tyr-48 is positioned in the helixloop-helix motif that is essential for protein binding. Currently, it is not clear whether PCB153-induced phosphoID3 leads to protein-protein interactions that may prevent
its degradation; however, our findings demonstrated that
ID3 is a target of posttranslational modifications by the
endocrine disruptor PCB153 in vascular endothelial cells.
Based on these lines of evidence, estrogenic chemical induced
ID3 signaling contributes to hyperplastic vascular lesions.
This vascular cell dysfunction may be a pathway by which
EDCs and ID3 contribute to cardiovascular disease [1].
Based on these findings, we propose that ID3 is a target
of EDCs that can activate inflammatory and energy pathways susceptible to metabolic perturbation during chronic
disease pathogenesis. In the next section, we intend to
discuss the current mechanistic understanding of how ID3
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may influence chronic diseases associated with metabolic
perturbations.

3. ID3 and Disease Outcomes
3.1. Vascular Diseases. ID3 involvement in vascular disease
has been studied together with the lipoxygenase (12/15-LO)
which is known to generate proinflammatory changes in
blood vessels that precede the development of atherosclerosis
[63]. 12/15-LO is an important mediator of VSMC growth
and its growth-promoting effects were shown to be mediated
by ID3 transcription [64]. Increased expression of 12/15LO in the vessel wall enhanced ID3-dependent cell proliferation, fibronectin deposition, and neointimal formation.
Population-based studies have found SNP (single nucleotide
polymorphisms) rs11574 in the coding region of the human
ID3 gene associated with subclinical atherosclerosis in the
Diabetes Heart Study [65]. ID3 SNP rs11574 showed a significant association of coronary artery disease for Caucasians
and to a lesser extent African Americans and Hispanics [66].
Ectopic expression of ID3 in VSMC (vascular smooth muscle
cells) regulates the cell cycle [67]. ID3 has also been shown
to play a complex role with atherosclerosis. ID3 expression
is increased by hyperlipidemia and oxidized LDL [26]. ID3
regulates angiotensin II and carotid intima-media thickness.
Angiotensin II promotes hyperplasia through upregulating
ID3 [68]. The ID3 SNP could be a potential loss of function
mutation if it inhibits the functioning of E proteins, thus
being an atheroprotective factor. As shown in Figure 2, ID3
may impact vascular cell dysfunction leading to intimal
lesions.
ID3 stimulates visceral adipose VEGFA expression, depot
expansion, and microvascular blood volume [5]. ID3 promotes angiogenesis in HFD- (high fat diet-) induced visceral
adiposity [5]. ID3 KO shows a protective effect from HFDinduced visceral fat depot expansion. Furthermore, HFDinduced VEGFA expression in visceral adipose tissue was
completely abolished by loss of ID3. BMP9 induces both ID1
and ID3 which are necessary for induction of Ephrin B2 [69].
A summary in Figure 2(b) shows an ID3 signaling pathway
involved in vascular malformations.
3.2. Neurological Disorders. The ID3 gene is biologically
relevant to neurological and behavior research because of
its involvement in the stress response, neural plasticity, and
neural circuitry. Molecular genetic studies in mice have
shown that ID3 is required for embryonic neurovascular
development. Genetic loss of ID1 and ID3 led to deviant
neurovascular formations resulting in death [12]. ID1 and ID3
mutants showed premature differentiation of CNS radial glial
cells that greatly increased neurons. Since radial glial cells
function as scaffolds for developing blood vessels in the CNS,
alterations to their development in ID1/ID3 knockout mice
may contribute to deviant blood vessel morphogenesis and
hemorrhage. ID1 and ID3 may function beyond maturation
of the CNS neurovasculature because other pathways such
as Notch1 activation do not support neurovascular disorders
[70, 71]. Psychopathologies such as anxiety and depression
have been associated with ID3 methylation status. Epigenetic
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ID3
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E12

Upregulated genes
Downregulated genes
MMP3, WNT4, MSLN, IL33
CXCL15, ALDH3A1, APCDD1,
CDH3, PTGS1, SEMA3A, FOXA2
PCDH21, SMPD3, TJP2, CTSC,
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FZD6, ANGPT2, EZR, ALDH1A2

SERPINA3, LECT1, SNAI1, GDF10
MEST, PTX3, APOE, PENK, COMP
LTBP2, CHI3L1, CNN1, MIA, GAS1
EMCN, S100B, DLX5, PECAM1
PDPN, MYCT1, HLA-DMB, SOX9
CCL9, CD93, CDH5, RGS4, GPX3
IL1R1, GFRA1, PRELP, GRB10
COL6A3, KRT18, ROR2, NFATC2
MFAP2, MDK, ANGPT4, PPP1R1B
ENPP2, CHST11, ICAM2, ST8SIA2

Atherogenesis

ID3

Intima-media thickness

Atheroma burden
Coronary artery calcium

Apoptosis
Cell movement
Adhesion
Cellular proliferation

Coronary arterial disease

Atherosclerosis

Immune trafficking
(a) ID3 molecular mechanism and vascular diseases. Summary illustration of ID3 signaling involved in vascular disease pathogenesis. ID3
signaling can lead to neointimal lesions or vascular remodeling by transcriptional regulation of the target genes described above (up- and
down regulated genes by ID3)

ID1
ID3

BMP9
ALK1

EPHRINB
Endothelial cell growth

VEGFR
Anastomosis
HESR1

Hereditary hemorrhagic
telangiectasia

Arteriovenous malformation

(b) ID3 involvement in arteriovenous malformation. Summary of experimental studies showing impact of ID3 in vascular cell dysfunction

Figure 2
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changes in ID3 have been associated with maltreatment of
children and demonstrated as a predictor for depression.
Montalvo-Ortiz et al. reported epigenetic alterations in DNA
derived from saliva in three genes predicted depression in a
cohort of maltreated children: ID3, Glutamate NMDA Receptor (GRIN1), and Tubulin Polymerization Promoting Protein
(TPPP) [72]. Studies of the expression of these genes from
medial prefrontal cortex (mPFC) tissue of mice are subjected
to a model of maternal neglect, which comprised maternal
separation and early weaning (MSEW). Behavioral tests were
performed in MSEW and control adult male mice by the
higher plus maze (EPM) and forced swimming test (FST),
respectively [72]. Behavioral differences in the EPM and FST
tests showed that these genes, ID3, GRIN1, and TPPP, could
predict anxiety and depression. Based on these studies, ID3
may contribute to the etiology of anxiety and depressive phenotypes when exposed to early life stress [72] (Figure 3(a)).
Both environmental and genetic factors contribute to
the progression of MetS and neurodegenerative disorders
[73]. Numerous studies have demonstrated that prediabetes
and diabetes mellitus support cognitive decline related to
Alzheimer’s disease (AD) and vascular dementia [73]. For
example, sucrose-treated mice develop mitochondrial abnormalities with significant increase in A𝛽 levels and slight
increase in pTau levels which links metabolic perturbations
from sucrose consumption with the AD-like pathology.
Epigenetic changes in ID3 have been associated with maltreatment of children and demonstrated as a predictor for
depression [74]. Another epigenetic study of individuals
with autism spectrum disorders (ASD) revealed a significant
association with a microRNA that targets ID3 [75]. This
is interesting as ID3 is also a neuronal target of MeCP2
which is the causative gene for Rett syndrome in which
afflicted children often exhibit autistic-like behaviors [76].
The overlap in the clinical symptoms of ASD, ADHD, and
neurodegenerative disorders raises the question of whether
epigenetic regulation of ID3 plays a role.
Population-based studies have demonstrated an association between toxic environmental chemical exposure and
impaired neurodevelopment that may impact neurobehavioral disorders [77]. Exposure to air pollutants from traffic
and coal emissions is well-known risk factors for both attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) [78]. Polychlorinated biphenyls (PCBs)
are endocrine disrupting chemicals shown to adversely
affect cognitive performance. Children exposed to PCBs
have shown behavioral impairments as well as significant
deficits in verbal and full-scale IQ [79]. Urban areas are
important regional sources of airborne PCBs and populationscale airborne exposure. Although PCBs have not been
intentionally produced in the USA since the late 1970s, they
continue to be detected in ambient air samples throughout
the world [80]. PCBs are measurable in the blood of nearly
80% of Americans over age 50 years [81]. Hence, exposure
to PCBs has been proposed to disrupt developing neuronal
circuits that may cause developmental brain disorders such
as learning disorders (LD), ADHD, and autism.
Endothelial cells of the blood-brain barrier (BBB) may
provide clues in the study of brain health, behavior, and
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the environment [4]. Inhaled air pollutants can disrupt the
BBB by inducing proinflammatory cytokines that act on
endothelial cells [82]. We have shown evidence for how
PCB-induced reactive oxygen species (ROS) may contribute
to cerebral vascular phenotype changes with the goal of
understanding consequences the environmental exposure
has on the BBB [28]. Toxic chemical exposure can change
brain gene expression through regulatory epigenetic mechanisms involving alterations in DNA methylation and histone acetylation. Evidence from animal studies show that
epigenetic programming by fetal exposure to toxicants has
long-lasting consequences for gene expression in the brain as
well as behavior [83]. Epigenetic changes in ID3 have been
associated with maltreatment of children and demonstrated
as a predictor for depression [74]. Epigenetic biomarkers in
peripheral tissues (blood, saliva, or buccal cells) may be useful
to predict neurodevelopmental disorders in humans. Exposure to prenatal stress, famine, and pollution/toxins, factors
known to affect brain development, has been associated with
epigenetic variation in human peripheral tissues [84]. Based
on these evidences, we postulate that ID3 can be a useful
biological marker of epigenetic perturbations caused by toxic
chemical exposure in children/adolescents (Figure 3(b)).
3.3. Kidney Disease. Lipoprotein abnormalities have been
reportedly linked to renal dysfunction in chronic kidney
disease patients. Nackiewicz et al. reviewed the prominent characteristics of kidney disease previously stated in
ApoE−/− ID3−/− double knockout mice and show that ID3 in
hyperlipidemic mice directly effects vulnerability to kidney
disease. ID3 deficiency may intensify CXCL1 production by
glomerular cells in response to inflammatory lipids and the
resulting macrophage recruitment. Because ID3 is present in
multiple cell types, it is also conceivable that other glomerular
cells lacking ID3 may contribute to cytokine production in
vivo [85]. Therefore, the renoprotective effect of ID3 may
be through regulation of local chemokine production. ID3
is known to directly interact with more than 30 different transcription factors [86]. Noticeably, a change in the
ID3 function may impact a wide range of protein-protein
interactions with potentially significant consequences [87].
In dissimilarity to the findings of Nachkiewicz et al., in
ApoE−/− ID3−/− mice with glomerulonephritis, the hyperlipidemic ID3−/− mice did not express meaningful increase
in glomerular immune complex deposition associated with
hyperlipidemic WT mice. Apolipoprotein E deficiency is
known to cause enlarged immune responsiveness [88] and
these results add significance to the study in dissecting the
effects of ID3 alone on kidney disease.
Clinical studies deliver indication for the relationship
between lipids and chronic kidney disease. Nevertheless, they
fail to elucidate why certain individuals (in the absence of
diabetes or MetS) are probable to develop chronic kidney
disease [89]. Increased susceptibility to atherosclerosis has
been reported to be associated with an ID3 single nucleotide
polymorphism (SNP) [65]. The overall preliminary findings
in humans suggest a significant association between the same
ID3 SNP and proteinuria, specifically influenced by small
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Figure 3

low density lipoproteins (𝑝 = 0.0024) [85]. C57BL/6 male
mice on high fat diets (60% calorie from fat) develop MetS
connected with obesity, elevated plasma glucose, proteinuria,
and glomerulonephritis (GN) and this may be due to decrease

in renal AMP activated protein kinase, a cellular energy
sensor [90]. However, C57BL/6 female mice on high fat diets
develop GN and proteinuria only in the absence of ID3
suggesting distinct pathogenic mechanisms between females
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and males. Examining molecular mechanisms in mice has
recognized ID3 as a unique transcription factor that may
contribute to kidney disease and provide mechanistic links
between atherosclerosis, hyperlipidemia, and kidney disease
in humans. A summary of ID3 pathway contributing to
chronic kidney disease is shown in Figure 4.
3.4. Cancer. Deregulation of ID genes is reported in human
cancers such as non-small cell lung cancer (NSCLC) and
colon cancer. ID3 contributes in generation of hematopoietic
stem and progenitor cells (HSPC) associated with myeloproliferative disease (MPD) [91]. ID1 and ID3 associated with
the tumor promotion and metastasis [92]. Poor response to
chemoradiotherapy has been reported in NSCLC patients
with elevated ID1 and ID3 protein expression [92]. Regulation of p21 by ID1 and ID3 has been seen as the vital
mechanism inhibiting the accumulation of additional DNA
damage and subsequent functional low energy of coloninitiating cells (CC-ICs). Genetic silencing of ID1 and ID3
increases chemotherapy sensitivity in CC-ICs suggesting that
these molecules allow cancer cells to be drug resistant [70].
Summary illustration of ID3 signaling involved in various
cancer pathways is shown in Figure 5(a).
Glioblastoma multiforme (GBM) tumors contain glioma
stem cells or GSCs which are implicated for glioma resistance
to treatment [93–97]. ID3 is also shown to be connected

with medulloblastoma in children [96]. Inhibition of ID3
reduced proliferation and migration and increased apoptosis
of medulloblastoma cells. Potential molecular mechanisms of
ID3 in brain cancer are shown in Figure 5(b).
3.5. Bone Disease. Osteogenesis imperfecta (OI) is a condition of fragile or brittle bones that break easily. OI affects 1 in
15,000 live births resulting in recurrent fractures and reduced
mobility, with significant influence on quality of life [98].
BMPs (bone morphogenetic proteins) are morphogenetic
signaling molecules vital for embryonic modelling. To find
molecular understanding into the effect of BMPs on morphogenesis, Hollnagel et al. examined novel genes directly
activated by BMP signaling. CDM- (chemically distinct
growth medium-) cultured ES cells reacted very stringently
to stimulation by numerous activin A, mesoderm inducers
(BMP2/4), and fibroblast growth factor [99]. Using cDNA
cloning, six BMP target genes were recognized. These include
ID3, which exhibited convincing mRNA initiation, and the
relatively stimulated Cyr61, DEK, and eIF4AII genes, as well
as a gene translating a GC-binding protein. Alongside ID1,
ID2, and ID3 genes were initiated by BMP4 in both ES cells
and arrangement of various cell lines. ID genes encode negative regulators of basic helix-loop-helix transcription factors.
In vivo, ectopic expression was observed of ID3 and Msx2 mRNAs in Ft/1 embryos at intersecting regions of ectopic
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BMP4 misexpression. As a result, Hollnagel et al. proposed
that the target genes of BMP4 signaling demonstrated here
are part of BMP-stimulated initial processes of mammalian
development. The expression arrangements of Msx-1, Msx2, c-jun, ID1, ID2, and ID3 in normal mice versus those
lacking in BMP2, BMP4, and BMP2/4-type I receptor will
be of distinctive interest to compare. The promoters of the
genes recognized in the analysis will aid as valuable tools to
illustrate the molecular governing circuits that are overseen
by BMP signaling [99].
ID proteins, including ID1, ID2, and ID3, are involved
with essential binding factor 𝛼-1 (Cbfa1) to trigger debilitated
transcription of the osteocalcin (OCL) and alkaline phosphatase (ALP) gene, commanding to weakened ALP action
and osteocalcin (OCL) production. ID acts by hindering the
specific-sequence binding of Cbfa1 to DNA and diminishing
the expression of Cbfa1 in cells experiencing osteogenic
differentiation [100]. Summary illustration of ID3 signaling
in OI or brittle bone disease is shown in Figure 6. p204,
an interferon-inducible protein that acts with both Cbfa1
and ID2, debilitated the ID2-mediated inhibition of Cbfa1induced ALP action and OCL production. Luan et al. establish that p204 interrupted the binding of ID2 to Cbfa1 and
facilitated Cbfa1 to bind to the promoters of its target genes.
Furthermore, p204 stimulated the translocation from nucleus
to the cytoplasm and enhanced the degradation of ID2 by
ubiquitin-proteasome pathway during osteogenesis. Nucleus
export signal (NES) of p204 is necessary for the p204enhanced cytoplasmic translocation and degradation of ID2,
since a p204 mutant-requiring NES lost these activities.

Taken together, ID proteins help to shape a regulatory circuit
and take part to control osteoblast differentiation [100].
ID1 and ID3 function to regulate bone metabolism in vivo
[101]. ID1/ID3 heterozygous knockout mice showed that the
thickness of calvarial junctions was attenuated by more than
50% [101]. Suppression of proliferation and mineralization in
osteoblasts resultant from ID1/ID3 heterozygous knockout
mice was proposed as a mechanism. Moreover, ID1/ID3
heterozygous knockout mice inhibited BMP-stimulated bone
development in vivo. Hence, ID1 and ID3 are critical regulators that support bone formation in vivo [101].
The connection between mechanisms of MetS and bone
mineral density (BMD) is controversial [102]. Von Muhlen
et al. examined the association of MetS with osteoporosis,
osteoporotic fractures, and BMD. MetS was associated with
decreased, not increased BMD. Frequency of osteoporotic
nonvertebral breakages was greater in members with MetS.
MetS may be an additional risk factor for osteoporotic fractures [102]. Occurrence of MetS at reference was 23.5% in men
and 18.2% in women. Age-adjusted analyses demonstrated in
both men and women with MetS had increased BMD at total
hip when compared to those without MetS (𝑝 < 0.001 and
𝑝 = 0.01, resp.). Men not women with MetS furthermore
had greater BMD at femoral neck (𝑝 = 0.05). Subsequently
modifying for BMI, these connections were inverted, such
that MetS was linked with decreased and not increased
BMD. Occurrence of osteoporotic nonvertebral breakages
was increased in participants with MetS. The connection of
MetS with increased BMD was explained by the increased
BMI in those with MetS [102].
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3.6. Autoimmune Diseases. MetS has been involved in
autoimmune diseases. One particular autoimmune disease
is primary Sjögren’s syndrome (pSS), which is primarily
categorized by inflammatory association of the exocrine
glands important to dry eye and mouth. Numerous organ
systems can be disturbed which can cause a wide variety
of extraglandular indicators, such as small airway disorders, multiple sclerosis-like disease, peripheral neuropathy
glomerulonephritis, and lymphoma [101]. pSS predominately
affects females (9 : 1), with a frequency in the overall population from 0.1 to 0.6%. Studies evaluating patients with
rheumatoid arthritis (RA) [2] and systemic lupus erythematosus (SLE) [103] have shown that inflammation plays a
role in the progression of hypertension, diabetes mellitus, and
MetS [104].
The ID3 gene is involved in the growth and function
of B and T cells. Deficient ID3 mice develop autoimmune
disease comparable to human primary Sjögren’s syndrome
(pSS). Together B and T lymphocytes have been involved
to contribute to the disease phenotype in this model [105].
The upregulation of ID1 and ID3 genes has been reported
in patients with rheumatoid arthritis (RA) [106]. Elevated
expression of ID1 and ID3 in endothelial cells has been
proposed to contribute to severe angiogenesis found in
RA.

4. Conclusion
We have comprehensively reviewed the existing evidence
to illustrate the association between ID3 and metabolic
perturbations. Furthermore, we extended this understanding
of how ID3 and metabolic perturbations by environmental
factors such as EDCs can modify chronic disease risk and
health outcomes. ID3 has been seen to interact with multiple
diseases such as cancer, vascular, neurological, autoimmune,
and bone diseases. Epidemiological and animal model studies have shown connections between ID3 and metabolic
perturbations in chronic disease. Research is warranted to
better define the influence of EDCs to ID3-induced metabolic
perturbations. This may lead to novel pathways for how the
interaction of ID3, EDCs, and metabolic disorders exacerbates complex chronic disease and can help public health
professionals control these metabolic disorders.
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